***Virtools S.A. Announces Complete Development Solution For
Interactive 3D Content in PC Games
Virtools S.A. announced the launch of its NeMo 3D interactive
authoring solutions for Microsoft Windows.
To support U.S. customers for NeMo, Virtools also announced the
expected opening of a North American sales and marketing office
in San Jose, effective 2nd quarter of 1999.
The NeMo product family is made up of 2 software solutions: NeMo
Dev and NeMo Creation. NeMo Creation is a package targeted at
independent multimedia authors and companies seeking to integrate
real-time interactive 3D into their content.
NeMo Creation includes:
* the NeMo core engine, the foundation of the NeMo technology
* the NeMo application (the end user graphic interface)
* the standard behavior building blocks library (including more
than 200 behavior building blocks)
* the NeMo Player (as a stand-alone exe file and as an Internet
Explorer/Netscape plug-in for Web deployment)
Unlike NeMo Creation, NeMo Dev is specifically designed to meet
the needs of 3D game development. It comes with all of the
features of NeMo Creation, and also includes the NeMo SDK, giving
developers low-level access to Virtools technology.
System Requirements
* Microsoft Windows NT 4.0, Windows 98 or Windows 95
* A Pentium(R) 200 or faster CPU (Pentium II recommended)
* 48 MB of RAM (64 MB recommended)
* 60 MB Hard Disk Space
* Direct3D or OpenGL compatible 3D accelerator card
NeMo Dev is priced at $3,490 US for a one-seat use license,
including six months tech support. The NeMo Creation tool is $990
US for a one-seat user license, including one month of tech
support. Both products will be available direct from Virtools at
the end of April - contact info@virtools.com for more details.
Virtools develops and markets interactive 3D content development
tools accessible to both programmers and artists. Virtools was
founded in 1993 with the mission to develop software solutions
for real-time 3D interactivity. Virtools received its first major
round of funding in 1997 through leading French Venture
Capitalists CDC-Innovation and Banexi Venture.
Wave Issue 9036 4/6/99 Article 1-05